Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Lisi Luo

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5015942602. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. TSPAN7 inhibits pancreatic cancer progression by suppressing DNA double-strand break repair and enhances sensitivity to immunochemotherapy. Co-author DOI 10.1016/j.bcp.2025.117199↗
  2. Molecular Classification of Genes Associated with Hypoxic Lipid Metabolism in Pancreatic Cancer. Co-author DOI 10.3390/biom12101533↗
  3. S100A16 induces epithelial-mesenchymal transition in human PDAC cells and is a new therapeutic target for pancreatic cancer treatment that synergizes with gemc… Co-author DOI 10.1016/j.bcp.2020.114396↗
  4. A new 7-gene survival score assay for pancreatic cancer patient prognosis prediction. Co-author PMID 33575083↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Linjuan Zeng · 4 shared papers, 2021–2025 · strength 0.64
  2. Yaning Li · 2 shared papers, 2022–2025 · strength 0.39
  3. Chumei Huang · 2 shared papers, 2021 · strength 0.25
  4. Yan Zeng · 1 shared paper, 2025 · strength 0.23
  5. Hai Lin · 1 shared paper, 2025 · strength 0.23
  6. Yutong Chen · 1 shared paper, 2022 · strength 0.16
  7. Ting Li · 1 shared paper, 2021 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.